Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:472-477
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwakura, K.
Right arrow Articles by Fujii, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwakura, K.
Right arrow Articles by Fujii, K.

CLINICAL STUDY

Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction

Katsuomi Iwakura, MD*, Hiroshi Ito, MD, FACC*, Shigeo Kawano, MD*, Yasunori Shintani, MD*, Koichi Yamamoto, MD*, Akinobu Kato, MD*, Masashi Ikushima, MD*, Koji Tanaka, MD*, Masashi Kitakaze, MD{dagger}, Masatsugu Hori, MD{dagger}, Yorihiko Higashino, MD* and Kenshi Fujii, MD*

* Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan
{dagger} Department of Internal Medicine and Therapeutics, Graduate School of Medicine, Osaka University, Osaka, Japan

Manuscript received January 31, 2001; revised manuscript received April 19, 2001, accepted April 27, 2001.

Reprint requests and correspondence: Dr. Hiroshi Ito, Division of Cardiology, Sakurabashi Watanabe Hospital, 2-4-32 Umeda, Kita-ku, Osaka 530-0001, Japan
itomd{at}osk4.3web.ne.jp

OBJECTIVES

We sought to elucidate the clinical factors related to the development of no-reflow phenomenon after successful coronary reperfusion in patients with an acute myocardial infarction (AMI).

BACKGROUND

Myocardial contrast echocardiography revealed that the no-reflow phenomenon is observed in some patients with a reperfused AMI, and those patients usually have poor functional and clinical outcomes. It is still unknown what clinical factors are related to the development of the no-reflow phenomenon.

METHODS

Myocardial contrast echocardiography was performed 15 min after successful coronary reperfusion therapy in 199 patients with an anterior wall AMI who underwent successful coronary reperfusion with primary coronary angioplasty within 24 h after the onset of AMI. Multiple logistic regression analysis was used to identify independent predictors of the no-reflow phenomenon.

RESULTS

Seventy-nine patients showed the no-reflow phenomenon. Univariate analysis indicated that pre-infarction angina within 48 h before symptom onset, Killip class, Thrombolysis in Myocardial Infarction flow grade 0 on the initial coronary angiogram, the number of abnormal Q-waves and the wall motion score (WMS) on the echocardiogram obtained at hospital admission are related to the no-reflow phenomenon. Multivariate logistic regression analysis revealed that all of these factors, except for Killip class, are independent predictive factors of the no-reflow phenomenon.

CONCLUSIONS

Development of the no-reflow phenomenon is related to the severity of myocardial damage (number of Q-waves), the size of the risk area (WMS) and the occlusion status of infarct-related artery. In addition, ischemic preconditioning (pre-infarction angina) seems to be the factor that attenuates the no-reflow phenomenon.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  ATP = adenosine triphosphate
  CK = creatine kinase
  ECG = electrocardiogram or electrocardiographic
  MCE = myocardial contrast echocardiography
  PTCA = percutaneous transluminal coronary angioplasty
  TIMI = Thrombolysis In Myocardial Infarction
  WMS = wall motion score




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea
Myocardial no-reflow in humans.
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 281 - 292.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Senior
Outcome after primary percutaneous intervention in acute myocardial infarction: role of microcirculatory perfusion--a crucial piece in the puzzle
Eur. Heart J., March 1, 2009; 30(5): 530 - 531.
[Full Text] [PDF]


Home page
HeartHome page
T Takahashi, Y Hiasa, Y Ohara, S Miyazaki, K Mahara, R Ogura, H Miyajima, K Yuba, N Suzuki, S Hosokawa, et al.
Acute hyperglycaemia prevents the protective effect of pre-infarction angina on microvascular function after primary angioplasty for acute myocardial infarction
Heart, November 1, 2008; 94(11): 1402 - 1406.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Hirsch, R. Nijveldt, J. D.E. Haeck, A. M. Beek, K. T. Koch, J. P.S. Henriques, R. J. van der Schaaf, M. M. Vis, J. Baan Jr, R. J. de Winter, et al.
Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction.
J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2230 - 2238.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. A. Hayat and R. Senior
Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?
Eur. Heart J., February 1, 2008; 29(3): 299 - 314.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. Dijkmans, R. Senior, H. Becher, T. R. Porter, K. Wei, C. A. Visser, and O. Kamp
Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2168 - 2177.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Niccoli, G. A. Lanza, S. Shaw, E. Romagnoli, D. Gioia, F. Burzotta, C. Trani, M. A. Mazzari, R. Mongiardo, M. De Vita, et al.
Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization
Eur. Heart J., August 1, 2006; 27(15): 1793 - 1798.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Iwakura, H. Ito, S. Kawano, A. Okamura, T. Kurotobi, M. Date, K. Inoue, and K. Fujii
Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction
Eur. Heart J., March 1, 2006; 27(5): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Tarantini, L. Cacciavillani, F. Corbetti, A. Ramondo, M. P. Marra, E. Bacchiega, M. Napodano, C. Bilato, R. Razzolini, and S. Iliceto
Duration of Ischemia Is a Major Determinant of Transmurality and Severe Microvascular Obstruction After Primary Angioplasty: A Study Performed With Contrast-Enhanced Magnetic Resonance
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1229 - 1235.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Kosuge, K. Kimura, T. Ishikawa, T. Ebina, K. Hibi, N. Toda, and S. Umemura
ST-Segment Depression in Lead aVR: A Useful Predictor of Impaired Myocardial Reperfusion in Patients With Inferior Acute Myocardial Infarction
Chest, August 1, 2005; 128(2): 780 - 786.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. P. Furber, F. Prunier, H. C. P. Nguyen, S. Boulet, S. Delepine, and P. Geslin
Coronary Blood Flow Assessment After Successful Angioplasty for Acute Myocardial Infarction Predicts the Risk of Long-Term Cardiac Events
Circulation, December 7, 2004; 110(23): 3527 - 3533.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
Heart, June 1, 2004; 90(6): e37 - e37.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kaul and H. Ito
Microvasculature in Acute Myocardial Ischemia: Part II: Evolving Concepts in Pathophysiology, Diagnosis, and Treatment
Circulation, January 27, 2004; 109(3): 310 - 315.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Mehta, K. J. Harjai, D. Cox, G. W. Stone, B. Brodie, J. Boura, W. O'Neill, C. L. Grines, and Primary Angioplasty in Myocardial Infarction (PAMI
Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1739 - 1746.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Iwakura
Reply
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2300 - 2300.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Iwakura, H. Ito, M. Ikushima, S. Kawano, A. Okamura, K. Asano, T. Kuroda, K. Tanaka, T. Masuyama, M. Hori, et al.
Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction
J. Am. Coll. Cardiol., January 1, 2003; 41(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.-K. Wong, J.K. French, M.W. Krucoff, W. Gao, P.E. Aylward, and H.D. White
Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion
Eur. Heart J., September 2, 2002; 23(18): 1449 - 1455.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement